Table 1.
Patient characteristics and surgical data.
| ATG Group (n=20) | BAS group (n=20) | p-value | |
|---|---|---|---|
| Age (years) | 60(±6) | 57 (±7) | 0.143 |
| Male, n (%) | 18 (90%) | 17 (85%) | 1 |
| Primary liver disease | 0.215 | ||
| Alcoholic | 11 (55%) | 11(55%) | |
| Hepatitis C | 4 (20%) | 8 (40%) | |
| HCC | 3 (15%) | 1 (5%) | |
| Hepatitis B | 1 (5%) | - | |
| NASH | 1 (5%) | - | |
| Pre-LT Arterial Hypertension, n (%) | 6 (30%) | 5 (25%) | 0.723 |
| Pre-LT Diabetes Mellitus, n (%) | 10 (50%) | 4 (20%) | 0.096 |
| Pre-LT Cardiologic Disease, n(%) | 4 (20%) | - | 0.106 |
| Median pre-eGFR (mL/min/1.73m 2 ) | 49±9 | 34±12 | 0.001 |
| MELD score | 20 (±7) | 26 (±9) | 0.065 |
| Cold ischemia time (min) | 325±85 | 370±96 | 0.070 |
| Warm ischemia time (min) | 45±19 | 39±10 | 0.254 |
| Intraoperative transfusion | |||
| Red blood cells (Unit) | 5 (0-26) | 6 (4-11) | 0.060 |
| Fresh Frozen Plasma (Unit) | 2 (0-18) | 8 (0-16) | 0.003 |
| Platelets (Unit) | 0 (0-10) | 2 (0-20) | 0.068 |
| Piggy-back with portacaval shunt | 11 (55%) | 17 (85%) | 0.082 |
| Hospital Stay (days) | 20 (11-90) | 15 (10-114) | 0.242 |
NASH, nonalcoholic steatohepatitis; eGFR, estimated glomerular filtration rate, and MELD; model for end-stage liver disease.